Interestingly, the HDAC inhibitor valproic acid also reduced the effect of paracrine CAF2 signaling in our co-culture screen, indicating that epigenetic marks may also regulate the ability of CAF2 to support hormone-independence in breast cancer cells. This evidence concerns the gene HDAC9 and breast cancer.